Radiation Biosciences Laboratory, Medical College of Wisconsin, Milwaukee, WI, United States of America.
Lawrence Berkeley National Laboratory, Berkeley, CA, United States of America.
PLoS One. 2023 Apr 26;18(4):e0283877. doi: 10.1371/journal.pone.0283877. eCollection 2023.
Long-duration space exploratory missions to the Earth's moon and the planet Mars are actively being planned. Such missions will require humans to live for prolonged periods beyond low earth orbit where astronauts will be continuously exposed to high energy galactic cosmic rays (GCRs). A major unknown is the potential impact of GCRs on the risks of developing degenerative cardiovascular disease, which is a concern to NASA. A ground-based rat model has been used to provide a detailed characterization of the risk of long-term cardiovascular disease from components of GCRs at radiation doses relevant to future human missions beyond low earth orbit. Six month old male WAG/RijCmcr rats were irradiated at a ground-based charged particle accelerator facility with high energy ion beams broadly representative of GCRs: protons, silicon and iron. Irradiation was given either as a single ion beam or as a combination of three ion beams. For the doses used, the single ion beam studies did not show any significant changes in the known cardiac risk factors and no evidence of cardiovascular disease could be demonstrated. In the three ion beam study, the total cholesterol levels in the circulation increased modestly over the 270 day follow up period, and inflammatory cytokines were also increased, transiently, 30 days after irradiation. Perivascular cardiac collagen content, systolic blood pressure and the number of macrophages found in the kidney and in the heart were each increased 270 days after irradiation with 1.5 Gy of the three ion beam grouping. These findings provide evidence for a cardiac vascular pathology and indicate a possible threshold dose for perivascular cardiac fibrosis and increased systemic systolic blood pressure for complex radiation fields during the 9 month follow up period. The development of perivascular cardiac fibrosis and increased systemic systolic blood pressure occurred at a physical dose of the three ion beam grouping (1.5 Gy) that was much lower than that required to show similar outcomes in earlier studies with the same rat strain exposed to photons. Further studies with longer follow up periods may help determine whether humans exposed to lower, mission-relevant doses of GCRs will develop radiation-induced heart disease.
长期的地球月球和行星火星探索任务正在积极规划中。这些任务将需要人类在低地球轨道以外的地方生活,在那里,宇航员将持续暴露在高能银河宇宙射线(GCRs)下。一个主要的未知数是 GCRs 对退行性心血管疾病风险的潜在影响,这是美国宇航局(NASA)关注的问题。地面大鼠模型已被用于详细描述与未来低地球轨道以外的人类任务相关的辐射剂量下,GCRs 成分对长期心血管疾病风险的影响。6 个月大的雄性 WAG/RijCmcr 大鼠在地面带电粒子加速器设施中用高能离子束辐照,这些离子束广泛代表 GCRs:质子、硅和铁。辐照要么是单一离子束,要么是三种离子束的组合。对于使用的剂量,单一离子束研究没有显示出任何已知心脏危险因素的显著变化,也没有证据表明存在心血管疾病。在三种离子束研究中,循环中的总胆固醇水平在 270 天的随访期间略有升高,炎症细胞因子也在辐照后 30 天短暂升高。辐照后 270 天,血管周围心脏胶原含量、收缩压和肾脏及心脏中发现的巨噬细胞数量均增加,三种离子束分组的 1.5 Gy 剂量。这些发现为心脏血管病理学提供了证据,并表明在 9 个月的随访期间,复杂辐射场中可能存在一个血管周围心脏纤维化和系统收缩压升高的阈值剂量。血管周围心脏纤维化和系统收缩压升高的发展发生在三种离子束分组(1.5 Gy)的物理剂量,远低于相同大鼠品系暴露于光子的早期研究中显示类似结果所需的剂量。进一步的长期随访研究可能有助于确定暴露于低剂量、与任务相关的 GCRs 的人类是否会发展为放射性心脏病。